Pell Bio-Med Technology Co., Ltd. (6949)
TWSE
Closed
Oct 12, 2026
Day's Range
45.3052 wk Range
44.35Overview - 6949 - Pell Bio-Med Technology Co., Ltd.
Key Statistics
Valuation
Enterprise Value
59.70B
P/E (Trailing)
‪-6.49‬
PEG Ratio
‪-2.28‬
Price / Sales (TTM)
‪2,123.21‬
Price / Book
‪23.86‬
EV / EBITDA
‪-129.06‬
Profitability
Gross Margin
‪-20.08%‬
Profit Margin
‪-13.97%‬
Operating Margin
‪-1,221.12%‬
Return on Assets
‪-12.91%‬
Return on Equity
‪-24.19%‬
Ownership
Shares Outstanding
65.55M
Float
684.59M
Held by Insiders
‪0.00%‬
Held by Institutions
‪1.27%‬
Price stats
Beta
‪1.33‬
50-Day Avg
‪520.65‬
200-Day Avg
‪637.09‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 6949 - Pell Bio-Med Technology Co., Ltd.
Peers - 6949 - Pell Bio-Med Technology Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 6949TWSEPell Bio-Med Technology Co., Ltd.61.22BMarket Cap-732.98%52-week change-6.49P/E (Trailing)‪-13.97%‬Profit Margin
- 6696TWSELin BioScience, Inc.149.25BMarket Cap+89.39%52-week change-108.13P/E (Trailing)‪0.00%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6586TWSECho Pharma Inc.24.82BMarket Cap+68.19%52-week change-85.29P/E (Trailing)‪74.49%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.22.58BMarket Cap-37.79%52-week change362.69P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.48BMarket Cap+0.38%52-week change26.53P/E (Trailing)‪36.97%‬Profit Margin
- 6547TWSEMedigen Vaccine Biologics Corporation20.38BMarket Cap+39.76%52-week change-72.21P/E (Trailing)‪-29.06%‬Profit Margin
Profile Summary - 6949 - Pell Bio-Med Technology Co., Ltd.
About
Pell Bio-Med Technology Co., Ltd. is a distinguished entity in the biotechnology and medical technology sectors. The company primarily focuses on the research, development, and manufacturing of advanced medical devices and diagnostic tools. Emphasizing innovation, Pell Bio-Med Technology Co., Ltd. creates cutting-edge…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
